Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia

Pediatric Hematology and Oncology

Volumn 24, Issue 4, 2007, Pages 257-267

  Kaya, Zühre ^a,b   Gursel, Türkiz ^a   Bakkaloglu, Sevcan A ^a   Kocak, Ulker ^a   Atasever, Tamer ^a   Oktar, Suna Ozhan ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Acute lymphoblastic leukemia; BFM 95 protocol; Nephrotoxicity

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FOLINATE CALCIUM; FOLINIC ACID; MERCAPTOPURINE; MESNA; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE TOXICITY; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION; HUMAN; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; MALE; MICROALBUMINURIA; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; TREATMENT DURATION; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LONGITUDINAL STUDIES; MALE; METHOTREXATE; PREDNISOLONE; TURKEY; VINCRISTINE;

EID: 34347399760     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010701441286     Document Type: Article

References (19)

1. Schilsky RL. Renal and metabolic toxicities of cancer chemotherapy. Semin Oncol. 1982;9:75-83.
2. Adamson PC, Balis FM, Berg S, et al. General principles of chemotherapy. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology, ed 5. Philadelphia: Williams & Wilkins; 2006:290-356.
3. Seidel H, Moe PJ, Nygaard R, et al. Evaluation of serious adverse events in patients treated with protocols including methotrexate infusions. Pediatr Hematol Oncol. 1994;11:165-172.
4. Deray G, Khayat D, Cacoub P, et al. The effects of diltiazem on methotrexate-induced nephrotoxicity. Eur J Clin Pharmacol. 1989;37:337-340.
5. Hempel L, Misselwitz J, Fleck C, et al. Influence of high dose methotrexate therapy on glomerular and tubular kidney function. Med Pediatr Oncol. 2003;40:348-354.
6. Goren MP, Baker DK, Sheenep JL. Vancomycin does not enhance amikacin induced tubular nephrotoxicity in children. Pediatr Infect Dis J. 1989;8:278-282.
7. Goren MP, Viar MJ, Sheenep JL, et al. Monitoring serum aminoglycoside concentrations in children with amphotericine B nephrotoxicity. Pediatr Infect Dis J. 1988;7:698-703.
8. Keeney RF, Kirk LE, Brigden D. Acyclovir tolerance in humans. Am J Med. 1982;73:176-181.
9. Hovi L, Koskimies O, Holmberg C, et al. Risk of progressive kidney damage after acute leukemia. Acta Paediatr Scand. 1989;78:608-614.
10. Yetgin S, Olgar Ş, Aras T, et al. Evaluation of kidney damage in patients with acute lymphoblastic leukemia in long term follow up: value of renal scan. Am J Hematol. 2004;77:132-139.
11. Bardi E, Olah AV, Bartyik K, et al. Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatr Blood Cancer. 2004;43:668-673.
12. Krawczuk-Rybak M, Kuzmicz M, Wysocka J. Renal function during and after treatment for acute lymphoblastic leukemia in children. Pediatr Nephrol. 2005;20:782-785.
13. Kakihara T, Imai C, Hotta H, et al. Impaired tubular excretory function as a late renal side effect of chemotherapy in children. J Pediatr Hematol Oncol. 2003;25:209-214.
14. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995 Berlin-Frankfurt-Munster. Leukemia. 2000;14:2205-2222.
15. Sikora P, Glatz S, Beck BB, et al. Urinary NAG in children with urolithiasis, nephrocalcinosis or risk of urolithiasis. Pediatr Nephrol. 2003;18:996-999.
16. Weber MH, Verwiebe R. α1 Microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction. Eur J Cl?n Chem. 1992;30:683-691.
17. Tomlinson PA. Low molecular weight proteins in children with renal disease. Pediatr Nephrol. 1992;6:565-571.
18. Kinoshita A, Kurosawa Y, Kondoh K, et al. Effects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2003;51:256-260.
19. Günel N, Coşkun U, Yamaç D, et al. Evaluation of serum cystatin C levels and 99 m technetium mercaptoacetyltriglycine-3 renal scintigraphy for the early detection of cisplatin induced renal toxicity in cancer patients. Nephrology. 2002;7:56-60.